PreveCeutical Medical Inc. (PRVCF)
USD 0.02
(6.4%)
USD 0.02
(6.4%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -9856.00 CAD | 0.35% |
| 2022 | -9891.00 CAD | -94.28% |
| 2021 | -5091.00 CAD | 93.23% |
| 2020 | -75.16 Thousand CAD | -3437.7% |
| 2019 | 2252.00 CAD | -79.01% |
| 2018 | 10.72 Thousand CAD | -24.97% |
| 2017 | 14.29 Thousand CAD | 791.44% |
| 2016 | -2068.00 CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2499.00 CAD | -2.0% |
| 2024 Q2 | -2522.00 CAD | -0.92% |
| 2023 Q2 | -2481.00 CAD | 0.32% |
| 2023 Q3 | -2436.00 CAD | 1.81% |
| 2023 Q1 | -2489.00 CAD | 62.14% |
| 2023 Q4 | -2450.00 CAD | -0.57% |
| 2023 FY | -9856.00 CAD | 0.35% |
| 2022 Q1 | -1126.00 CAD | -60.4% |
| 2022 FY | -9891.00 CAD | -94.28% |
| 2022 Q4 | -6574.00 CAD | -505.34% |
| 2022 Q3 | -1086.00 CAD | 1.72% |
| 2022 Q2 | -1105.00 CAD | 1.87% |
| 2021 Q1 | -1530.00 CAD | 0.0% |
| 2021 Q4 | -702.00 CAD | 48.38% |
| 2021 Q3 | -1360.00 CAD | 9.21% |
| 2021 Q2 | -1498.00 CAD | 2.09% |
| 2021 FY | -5091.00 CAD | 93.23% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 FY | -75.16 Thousand CAD | -3437.7% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 Q2 | -16.00 CAD | -100.71% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 100.0% |
| 2019 FY | 2252.00 CAD | -79.01% |
| 2019 Q1 | 2268.00 CAD | 625.0% |
| 2018 Q1 | 1140.00 CAD | -65.77% |
| 2018 FY | 10.72 Thousand CAD | -24.97% |
| 2018 Q2 | 9626.00 CAD | 744.39% |
| 2018 Q3 | 396.00 CAD | -95.89% |
| 2018 Q4 | -432.00 CAD | -209.09% |
| 2017 Q3 | 7300.00 CAD | 71.85% |
| 2017 FY | 14.29 Thousand CAD | 791.44% |
| 2017 Q1 | -11.27 Thousand CAD | 27.85% |
| 2017 Q2 | 4248.00 CAD | 137.67% |
| 2017 Q4 | 3330.00 CAD | -54.38% |
| 2016 Q3 | -8138.00 CAD | -229.21% |
| 2016 FY | -2068.00 CAD | 0.0% |
| 2016 Q1 | -1319.00 CAD | 0.0% |
| 2016 Q4 | -15.62 Thousand CAD | -92.04% |
| 2016 Q2 | -2472.00 CAD | -87.41% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 102.043% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 102.403% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.084% |
| GB Sciences, Inc. | -624.00 USD | -1479.487% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 92.068% |
| Zenith Capital Corp. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -304.1% |
| Biomind Labs Inc. | -15.42 Thousand USD | 36.1% |
| ContraFect Corporation | -154 Thousand USD | 93.6% |
| CSL Limited | 7.56 Billion USD | 100.0% |
| CytoDyn Inc. | -29 Thousand USD | 66.014% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.962% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 79.577% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 71.139% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 105.582% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.008% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.101% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 115.839% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.066% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 114.995% |
| Mesoblast Limited | -35.16 Million USD | 99.972% |
| Marizyme, Inc. | 457.7 Thousand USD | 102.153% |
| Genus plc | 178.7 Million USD | 100.006% |
| Pharming Group N.V. | 220.1 Million USD | 100.004% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 10.4% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 112.84% |
| IMV Inc. | -962.29 Thousand USD | 98.976% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 97.457% |
| MultiCell Technologies, Inc. | 49.32 USD | 20083.779% |
| ONE Bio Corp. | 20.12 Million USD | 100.049% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.024% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.035% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 99.137% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 114.08% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -99.031% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 107.015% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 88.543% |
| Enzolytics Inc. | 30.7 Thousand USD | 132.096% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.001% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 98.084% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.002% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 417.73% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -11.292% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 88.246% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 80.288% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 100.998% |
| EV Biologics, Inc. | 48.9 Thousand USD | 120.155% |
| Q BioMed Inc. | -8988.00 USD | -9.657% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.103% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.022% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.064% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 89.893% |
| HST Global, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -4638.462% |
| Resverlogix Corp. | - USD | Infinity% |
| Cell Source, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 101.596% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 98.436% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 16.722% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 105.582% |
| Affymax, Inc. | 1.35 Million USD | 100.726% |
| Itoco Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 100.214% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -8285.00 USD | -18.962% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 102.19% |
| SYBLEU INC | 11.69 Thousand USD | 184.268% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 96.915% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 97.358% |
| Neutra Corp. | 14.33 Thousand USD | 168.755% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 87.98% |
| PureTech Health plc | -1.6 Million USD | 99.385% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 99.016% |
| IXICO plc | 3.27 Million USD | 100.301% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 98.58% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 99.45% |
| CSL Limited | 7.7 Billion USD | 100.0% |
| Cellectis S.A. | 18 Thousand USD | 154.756% |